两种体位激发试验对醛固酮瘤的诊断价值

  • 摘要: 目的:对临床确诊醛固酮瘤患者,比较单纯体位激发试验及体位联合呋塞米双重激发试验对肾素活性(PRA)、醛固酮(ALD)、醛固酮/肾素比值(ARR)的影响。方法:对112例经我院手术切除并行病理检查确诊为醛固酮瘤(APA)的患者进行回顾性统计分析, 其中60例术前行单纯体位激发试验,52例行体位加呋塞米双重激发试验,比较两组患者的一般情况、PRA、ALD数值,并计算ARR。结果:进行双重激发与单纯体位激发试验患者的一般情况、PRA、ALD、ARR均无显著性差异,而不良反应在双重激发组中更多见,与单纯体位激发组相比差异有显著性意义。结论:在体位激发试验中是否加用呋塞米对APA患者的ARR影响不大,反而增加了不良反应的发生率。

     

    Abstract: Objective:To study the changes of the plasma rennin activity (PRA), aldosterone (ALD) and aldosterone/rennin ratio (ARR) in response to posture test alone or posture-furosemide test (double stimulation) in patients confirmed with aldsterone-producing adenoma (APA). Methods:Retrospective chart review was conducted in a total of 112 APA patients who were confirmed by surgery and postoperative biopsy. Posture test alone was performed in 60 patients, and posture-furosemide test was done in 52 patients before surgery. Clinical characteristics, PRA, ALD, and ARR were compared. Results:No significant differences were observed between the two groups in clinical characteristics, PRA, ALD or ARR, whereas the frequency of side-effect related to the tests was higher in the group using double-stimulation. Conclusion:There isn’t much difference whether furosemide is added to posture test for the evaluation of APA, it may increase side-effects instead.

     

/

返回文章
返回